Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry-Reference-Cited by-同舟云学术

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry

Published:2021-04 Issue:4 Volume:14 Page:100535
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Valerieva Anna,Staevska Maria T.,Grivcheva-Panovska Vesna,Jesenak Milos,Kőhalmi Kinga Viktória,Hrubiskova Katarina,Zanichelli Andrea,Bellizzi Luca,Relan Anurag,Hakl Roman,Farkas Henriette

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Epidemiology of bradykinin-mediated angioedema: a systematic investigation of epidemiological studies;Aygören-Pürsün;Orphanet J Rare Dis,2018

2. Clinical practice. Hereditary angioedema;Zuraw;N Engl J Med,2008

3. The international WAO/EAACI guideline for the management of hereditary angioedema — the 2017 revision and update;Maurer;Allergy,2018

4. Ruconest® (C1 esterase inhibitor [recombinant]) for intravenous use, lyophilized powder for reconstitution [package insert],2020

5. Ruconest Summary of Product Characteristics,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and therapeutic value of human serpin family proteins;Biomedicine & Pharmacotherapy;2024-06

2. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system;Journal of Translational Medicine;2024-04-26

3. The role of disease registers in dermatology;British Journal of Dermatology;2024-01-04

4. Selection and characterization of a peptide-based complement modulator targeting C1 of the innate immune system;RSC Chemical Biology;2024

5. Initial use of subcutaneous plasma-derived C1 inhibitor in prophylaxis of acute attacks of hereditary angioedema in pregnant patients in Slovakia;Vnitřní lékařství;2023-06-22